Weiss Amir 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Weiss Amir（CIK 1897057）在 1 家公司共报告 10 笔 SEC Form 4 内部人交易（最近一笔 2026-08-25）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-25 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | 卖出 | 6,945 | $261,224 |
| 2026-08-25 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | 买入 | 2,500 | $49,025 |
| 2026-08-25 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | 卖出 | 2,500 | $94,077 |
| 2026-05-07 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | 卖出 | 10,679 | $384,444 |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | 买入 | 3,537 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | 买入 | 10,679 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | 买入 | 5,650 | $0 |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | 买入 | 5,179 | $0 |
| 2025-12-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | 卖出 | 12,300 | $371,460 |
| 2025-11-10 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | 卖出 | 12,300 | $300,612 |
来源：SEC Form 4 申报文件 · 截至 2026-08-25